Ann Surg Oncol (2018) 25:2249–2260 https://doi.org/10.1245/s10434-018-6533-3 OR IG INA L A R TIC L E – BREA S T O NC OLOG Y Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database 1 2 3,4 1,4 Cecilia T. Ong, MD , Brittany M. Campbell, BS , Samantha M. Thomas, MS , Rachel A. Greenup, MD , 1,4 1,4 4,5 4,6 Jennifer K. Plichta, MD , Laura H. Rosenberger, MD , Jeremy Force, DO , Allison Hall, MD , Terry Hyslop, 3,4 1,4 1,4 PhD , E. Shelley Hwang, MD , and Oluwadamilola M. Fayanju, MD 1 2 Department of Surgery, Duke University Medical Center, Durham, NC; Duke University School of Medicine, Durham, 3 4 NC; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC; Duke Cancer 5 6 Institute, Durham, NC; Department of Medical Oncology, Duke University Medical Center, Durham, NC; Department of Pathology, Duke University Medical Center, Durham, NC ABSTRACT [CI] 0.88–1.54, p = 0.28). Compared with non-MBC Background. Metaplastic breast cancer (MBC) is char- patients, MBC patients were more likely to receive mas- acterized by chemoresistance and hematogenous spread. tectomy (59.0 vs. 44.9%), chemotherapy (74.1 vs.
Annals of Surgical Oncology – Springer Journals
Published: May 31, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud